Mid-market scale Raritan Pharmaceuticals is a mid-sized pharma manufacturer with an employee base of 51-200 and annual revenue in the $50M-$100M range, indicating a sizable operations footprint that could benefit from enterprise-grade procurement, manufacturing optimization, and scalable support services.

Digital footprint The company uses common web and analytics technologies (WordPress, Google Analytics, Google Tag Manager, Microsoft 365) suggesting potential opportunities for digital marketing integration, IT modernization, cybersecurity services, and data-driven marketing optimization.

Strategic partnerships Operating in pharmaceutical manufacturing with notable peers in the industry, Raritan could be open to collaborations in contract manufacturing, supply chain enhancements, and technology transfers to improve efficiency and expand product capabilities.

Growth readiness With revenues in the $50M-$100M range and growth-oriented peers, there may be appetite for capex-friendly solutions, regulatory-compliant manufacturing enhancements, and scalable ERP or MES systems to support expanding production lines.

Security and compliance Adoption of standard tech stack components implies value in strengthening cybersecurity, data privacy, and compliance services aligned with pharma industry requirements, potentially reducing risk across IT and manufacturing operations.